Your browser doesn't support javascript.
loading
Reparixin, a CXCR1/2 inhibitor in islet allotransplantation.
Pawlick, Rena L; Wink, John; Pepper, Andrew R; Bruni, Antonio; Abualhassen, Nasser; Rafiei, Yasmin; Gala-Lopez, Boris; Bral, Mariusz; Shapiro, A M James.
Affiliation
  • Pawlick RL; a Alberta Diabetes Institute, University of Alberta , Edmonton , AB , Canada.
  • Wink J; a Alberta Diabetes Institute, University of Alberta , Edmonton , AB , Canada.
  • Pepper AR; a Alberta Diabetes Institute, University of Alberta , Edmonton , AB , Canada.
  • Bruni A; a Alberta Diabetes Institute, University of Alberta , Edmonton , AB , Canada.
  • Abualhassen N; a Alberta Diabetes Institute, University of Alberta , Edmonton , AB , Canada.
  • Rafiei Y; a Alberta Diabetes Institute, University of Alberta , Edmonton , AB , Canada.
  • Gala-Lopez B; a Alberta Diabetes Institute, University of Alberta , Edmonton , AB , Canada.
  • Bral M; a Alberta Diabetes Institute, University of Alberta , Edmonton , AB , Canada.
  • Shapiro AM; a Alberta Diabetes Institute, University of Alberta , Edmonton , AB , Canada.
Islets ; 8(5): 115-24, 2016 09 02.
Article in En | MEDLINE | ID: mdl-27328412
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Islets of Langerhans Transplantation / Diabetes Mellitus, Experimental / Diabetes Mellitus, Type 1 / Graft Rejection / Graft Survival Aspects: Patient_preference Limits: Animals Language: En Journal: Islets Year: 2016 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Islets of Langerhans Transplantation / Diabetes Mellitus, Experimental / Diabetes Mellitus, Type 1 / Graft Rejection / Graft Survival Aspects: Patient_preference Limits: Animals Language: En Journal: Islets Year: 2016 Document type: Article